ADBE Adobe | $536.87
-8.5% | 9/13/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $625.00 -> $625.00 | High | View details for Oppenheimer rating of Adobe (NASDAQ:ADBE) on 9/13/2024 |
JEF Jefferies Financial Group | $58.54
+1.7% | 9/13/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $64.00 -> $66.00 | Low | View details for Oppenheimer rating of Jefferies Financial Group (NYSE:JEF) on 9/13/2024 |
MRNA Moderna | $68.28
-2.0% | 9/13/2024 | Downgraded by | Oppenheimer | - | Outperform -> Market Perform | | High | View details for Oppenheimer rating of Moderna (NASDAQ:MRNA) on 9/13/2024 |
SABS SAB Biotherapeutics | $2.79
+0.7% | 9/12/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $12.00 -> $12.00 | Low | View details for Oppenheimer rating of SAB Biotherapeutics (NASDAQ:SABS) on 9/12/2024 |
EW Edwards Lifesciences | $68.52
+0.6% | 9/12/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $90.00 -> $90.00 | Low | View details for Oppenheimer rating of Edwards Lifesciences (NYSE:EW) on 9/12/2024 |
ZWS Zurn Elkay Water Solutions | $32.87
+1.2% | 9/12/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $37.00 -> $37.00 | Low | View details for Oppenheimer rating of Zurn Elkay Water Solutions (NYSE:ZWS) on 9/12/2024 |
|
MOD Modine Manufacturing | $111.07
+0.2% | 9/12/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $135.00 -> $135.00 | Low | View details for Oppenheimer rating of Modine Manufacturing (NYSE:MOD) on 9/12/2024 |
BIOX Bioceres Crop Solutions | $8.56
-0.5% | 9/11/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $17.00 -> $16.00 | Low | View details for Oppenheimer rating of Bioceres Crop Solutions (NASDAQ:BIOX) on 9/11/2024 |
IFF International Flavors & Fragrances | $103.59
+0.1% | 9/11/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $116.00 -> $117.00 | Low | View details for Oppenheimer rating of International Flavors & Fragrances (NYSE:IFF) on 9/11/2024 |
AVBP ArriVent BioPharma | $23.76
-0.1% | 9/10/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $35.00 -> $39.00 | Low | View details for Oppenheimer rating of ArriVent BioPharma (NASDAQ:AVBP) on 9/10/2024 |
ORCL Oracle | $162.03
+0.4% | 9/10/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Medium | View details for Oppenheimer rating of Oracle (NYSE:ORCL) on 9/10/2024 |
AAPL Apple | $222.50
-0.1% | 9/10/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $250.00 -> $250.00 | Low | View details for Oppenheimer rating of Apple (NASDAQ:AAPL) on 9/10/2024 |
RLAY Relay Therapeutics | $7.60
-0.3% | 9/10/2024 | Downgraded by | Oppenheimer | - | Outperform -> Market Perform | | High | View details for Oppenheimer rating of Relay Therapeutics (NASDAQ:RLAY) on 9/10/2024 |
NDAQ Nasdaq | $73.00
+0.6% | 9/9/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $78.00 -> $80.00 | Low | View details for Oppenheimer rating of Nasdaq (NASDAQ:NDAQ) on 9/9/2024 |
LYV Live Nation Entertainment | $98.85
+1.6% | 9/6/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $110.00 -> $120.00 | Low | View details for Oppenheimer rating of Live Nation Entertainment (NYSE:LYV) on 9/6/2024 |
PHVS Pharvaris | $20.92
+1.9% | 9/6/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $38.00 -> $42.00 | Low | View details for Oppenheimer rating of Pharvaris (NASDAQ:PHVS) on 9/6/2024 |
COST Costco Wholesale | $916.00
+0.1% | 9/6/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $925.00 -> $955.00 | Low | View details for Oppenheimer rating of Costco Wholesale (NASDAQ:COST) on 9/6/2024 |
DPZ Domino's Pizza | $402.52
-0.8% | 9/6/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $510.00 -> $490.00 | Low | View details for Oppenheimer rating of Domino’s Pizza (NYSE:DPZ) on 9/6/2024 |
GWRE Guidewire Software | $171.81
+1.2% | 9/6/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $170.00 -> $185.00 | Low | View details for Oppenheimer rating of Guidewire Software (NYSE:GWRE) on 9/6/2024 |
AI C3.ai | $23.00
+0.6% | 9/5/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $40.00 -> $40.00 | Low | View details for Oppenheimer rating of C3.ai (NYSE:AI) on 9/5/2024 |
BASE Couchbase | $14.86
+0.2% | 9/5/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $25.00 -> $23.00 | Low | View details for Oppenheimer rating of Couchbase (NASDAQ:BASE) on 9/5/2024 |
PNST Pinstripes | $1.23
-5.4% | 9/5/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $6.00 -> $5.00 | Low | View details for Oppenheimer rating of Pinstripes (NYSE:PNST) on 9/5/2024 |
ASND Ascendis Pharma A/S | $119.22
+4.8% | 9/5/2024 | Upgraded by | Oppenheimer | - | Market Perform -> Outperform | $180.00 | Low | View details for Oppenheimer rating of Ascendis Pharma A/S (NASDAQ:ASND) on 9/5/2024 |
NRIX Nurix Therapeutics | $24.80
+5.2% | 9/4/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $27.00 -> $30.00 | Low | View details for Oppenheimer rating of Nurix Therapeutics (NASDAQ:NRIX) on 9/4/2024 |
ASAN Asana | $12.12
+3.5% | 9/4/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $23.00 -> $20.00 | Low | View details for Oppenheimer rating of Asana (NYSE:ASAN) on 9/4/2024 |
CSL Carlisle Companies | $411.30
+1.8% | 9/4/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $475.00 -> $480.00 | Low | View details for Oppenheimer rating of Carlisle Companies (NYSE:CSL) on 9/4/2024 |
PRAX Praxis Precision Medicines | $59.88
+2.0% | 9/4/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $134.00 -> $143.00 | Low | View details for Oppenheimer rating of Praxis Precision Medicines (NASDAQ:PRAX) on 9/4/2024 |
ZS Zscaler | $170.06
+2.0% | 9/4/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $260.00 -> $230.00 | Low | View details for Oppenheimer rating of Zscaler (NASDAQ:ZS) on 9/4/2024 |
ADBE Adobe | $536.87
-8.5% | 9/4/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $580.00 -> $625.00 | Low | View details for Oppenheimer rating of Adobe (NASDAQ:ADBE) on 9/4/2024 |
DYN Dyne Therapeutics | $34.06
+3.0% | 9/3/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $55.00 -> $55.00 | Low | View details for Oppenheimer rating of Dyne Therapeutics (NASDAQ:DYN) on 9/3/2024 |
BLDR Builders FirstSource | $183.30
+4.3% | 9/3/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $190.00 -> $205.00 | Low | View details for Oppenheimer rating of Builders FirstSource (NYSE:BLDR) on 9/3/2024 |
FICO Fair Isaac | $1,868.96
+0.4% | 9/3/2024 | Initiated by | Oppenheimer | - | Outperform | $1,967.00 | Low | View details for Oppenheimer rating of Fair Isaac (NYSE:FICO) on 9/3/2024 |
ADSK Autodesk | $263.96
+1.7% | 8/30/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $275.00 -> $300.00 | Low | View details for Oppenheimer rating of Autodesk (NASDAQ:ADSK) on 8/30/2024 |
ULTA Ulta Beauty | $378.34
+1.4% | 8/30/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $450.00 -> $435.00 | Low | View details for Oppenheimer rating of Ulta Beauty (NASDAQ:ULTA) on 8/30/2024 |
ESTC Elastic | $75.24
+1.9% | 8/30/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $150.00 -> $125.00 | Low | View details for Oppenheimer rating of Elastic (NYSE:ESTC) on 8/30/2024 |
MDB MongoDB | $290.09
-1.7% | 8/30/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $300.00 -> $350.00 | Low | View details for Oppenheimer rating of MongoDB (NASDAQ:MDB) on 8/30/2024 |
CRM Salesforce | $254.57
+0.5% | 8/29/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $280.00 -> $300.00 | Low | View details for Oppenheimer rating of Salesforce (NYSE:CRM) on 8/29/2024 |
CRWD CrowdStrike | $259.13
+0.8% | 8/29/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $450.00 -> $365.00 | Low | View details for Oppenheimer rating of CrowdStrike (NASDAQ:CRWD) on 8/29/2024 |
UTHR United Therapeutics | $339.12
-0.6% | 8/28/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $400.00 -> $575.00 | Low | View details for Oppenheimer rating of United Therapeutics (NASDAQ:UTHR) on 8/28/2024 |
MNKD MannKind | $6.27
+1.1% | 8/28/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $10.00 -> $12.00 | Low | View details for Oppenheimer rating of MannKind (NASDAQ:MNKD) on 8/28/2024 |
War on Elon Escalates… (Ad) Elon Musk just built a supercomputer in Memphis, Tennessee.
It took him only 122 days.
Dubbed “Colossus,” this supercomputer aims to become the most powerful AI training system in the world.
Housed in a 785,000 sq. ft facility in Memphis, Colossus will soon require 150 megawatts of electricity per day.
That’s about equal to the amount of energy needed to power 100,000 homes per year.  Click here and take notes. |
ENGN enGene | $6.69
+0.6% | 8/28/2024 | Initiated by | Oppenheimer | - | Outperform | $30.00 | Low | View details for Oppenheimer rating of enGene (NASDAQ:ENGN) on 8/28/2024 |
SABS SAB Biotherapeutics | $2.79
+0.7% | 8/28/2024 | Initiated by | Oppenheimer | - | Outperform | $12.00 | Low | View details for Oppenheimer rating of SAB Biotherapeutics (NASDAQ:SABS) on 8/28/2024 |
ENVX Enovix | $9.70
+3.9% | 8/26/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $36.00 -> $36.00 | Low | View details for Oppenheimer rating of Enovix (NASDAQ:ENVX) on 8/26/2024 |
TRDA Entrada Therapeutics | $15.00
+0.9% | 8/26/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $25.00 -> $25.00 | Low | View details for Oppenheimer rating of Entrada Therapeutics (NASDAQ:TRDA) on 8/26/2024 |
DG Dollar General | $84.75
+1.9% | 8/26/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Dollar General (NYSE:DG) on 8/26/2024 |
SBUX Starbucks | $98.57
-0.7% | 8/26/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Starbucks (NASDAQ:SBUX) on 8/26/2024 |
CSIQ Canadian Solar | $13.98
+0.6% | 8/23/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $43.00 -> $27.00 | Low | View details for Oppenheimer rating of Canadian Solar (NASDAQ:CSIQ) on 8/23/2024 |
ADI Analog Devices | $225.42
+1.8% | 8/22/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $245.00 -> $245.00 | Low | View details for Oppenheimer rating of Analog Devices (NASDAQ:ADI) on 8/22/2024 |
ALC Alcon | $98.50
-2.2% | 8/22/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $103.00 -> $110.00 | N/A | View details for Oppenheimer rating of Alcon (NYSE:ALC) on 8/22/2024 |
TOL Toll Brothers | $149.80
+3.4% | 8/22/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $157.00 -> $168.00 | Low | View details for Oppenheimer rating of Toll Brothers (NYSE:TOL) on 8/22/2024 |
CRGO Freightos | $1.43
-5.6% | 8/21/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $4.50 -> $3.50 | Low | View details for Oppenheimer rating of Freightos (NASDAQ:CRGO) on 8/21/2024 |
MDT Medtronic | $90.00
| 8/21/2024 | Target Raised by | Oppenheimer | - | Market Perform -> Market Perform | $92.00 -> $94.00 | Low | View details for Oppenheimer rating of Medtronic (NYSE:MDT) on 8/21/2024 |
PANW Palo Alto Networks | $346.90
+0.5% | 8/20/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $390.00 -> $410.00 | Low | View details for Oppenheimer rating of Palo Alto Networks (NASDAQ:PANW) on 8/20/2024 |
GWRE Guidewire Software | $171.81
+1.2% | 8/20/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $140.00 -> $170.00 | Low | View details for Oppenheimer rating of Guidewire Software (NYSE:GWRE) on 8/20/2024 |
ACA Arcosa | $91.34
+4.1% | 8/19/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $100.00 -> $105.00 | Low | View details for Oppenheimer rating of Arcosa (NYSE:ACA) on 8/19/2024 |
SACH Sachem Capital | $2.55
-2.3% | 8/19/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $4.50 -> $4.00 | N/A | View details for Oppenheimer rating of Sachem Capital (NYSEAMERICAN:SACH) on 8/19/2024 |
KALA KALA BIO | $5.91
-0.7% | 8/19/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $15.00 -> $15.00 | Low | View details for Oppenheimer rating of KALA BIO (NASDAQ:KALA) on 8/19/2024 |
DMAC DiaMedica Therapeutics | $4.50
+4.9% | 8/16/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $6.00 -> $6.00 | Low | View details for Oppenheimer rating of DiaMedica Therapeutics (NASDAQ:DMAC) on 8/16/2024 |
CARR Carrier Global | $76.51
+1.5% | 8/16/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $70.00 -> $74.00 | Low | View details for Oppenheimer rating of Carrier Global (NYSE:CARR) on 8/16/2024 |
ULTA Ulta Beauty | $378.34
+1.4% | 8/15/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $450.00 -> $450.00 | Low | View details for Oppenheimer rating of Ulta Beauty (NASDAQ:ULTA) on 8/15/2024 |
SG Sweetgreen | $34.58
+1.9% | 8/15/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $36.00 -> $40.00 | Low | View details for Oppenheimer rating of Sweetgreen (NYSE:SG) on 8/15/2024 |
ACHV Achieve Life Sciences | $4.53
+4.1% | 8/15/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $11.00 -> $11.00 | Low | View details for Oppenheimer rating of Achieve Life Sciences (NASDAQ:ACHV) on 8/15/2024 |
AVBP ArriVent BioPharma | $23.76
-0.1% | 8/15/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $35.00 -> $35.00 | Low | View details for Oppenheimer rating of ArriVent BioPharma (NASDAQ:AVBP) on 8/15/2024 |
WMS Advanced Drainage Systems | $147.58
+2.2% | 8/15/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $192.00 -> $192.00 | Low | View details for Oppenheimer rating of Advanced Drainage Systems (NYSE:WMS) on 8/15/2024 |
VXRT Vaxart | $0.99
+8.7% | 8/15/2024 | Initiated by | Oppenheimer | - | Outperform | $4.00 | Low | View details for Oppenheimer rating of Vaxart (NASDAQ:VXRT) on 8/15/2024 |
PRAX Praxis Precision Medicines | $59.88
+2.0% | 8/14/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $134.00 -> $134.00 | Low | View details for Oppenheimer rating of Praxis Precision Medicines (NASDAQ:PRAX) on 8/14/2024 |
RGLS Regulus Therapeutics | $1.61
+1.9% | 8/14/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $7.00 -> $7.00 | Low | View details for Oppenheimer rating of Regulus Therapeutics (NASDAQ:RGLS) on 8/14/2024 |
CNTA Centessa Pharmaceuticals | $16.99
+12.5% | 8/14/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $14.00 -> $14.00 | Low | View details for Oppenheimer rating of Centessa Pharmaceuticals (NASDAQ:CNTA) on 8/14/2024 |
GANX Gain Therapeutics | $1.47
-0.3% | 8/14/2024 | Reiterated by | Oppenheimer | - | Outperform | $8.00 | Low | View details for Oppenheimer rating of Gain Therapeutics (NASDAQ:GANX) on 8/14/2024 |
TGT Target | $151.36
+2.0% | 8/14/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $200.00 -> $180.00 | Low | View details for Oppenheimer rating of Target (NYSE:TGT) on 8/14/2024 |
FLUT Flutter Entertainment | $221.47
+0.9% | 8/14/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $240.00 -> $255.00 | Low | View details for Oppenheimer rating of Flutter Entertainment (NYSE:FLUT) on 8/14/2024 |
PRTA Prothena | $22.11
+6.7% | 8/14/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $66.00 -> $62.00 | Low | View details for Oppenheimer rating of Prothena (NASDAQ:PRTA) on 8/14/2024 |
QUIK QuickLogic | $7.65
+1.7% | 8/14/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $16.00 -> $13.00 | Low | View details for Oppenheimer rating of QuickLogic (NASDAQ:QUIK) on 8/14/2024 |
NRIX Nurix Therapeutics | $24.80
+5.2% | 8/14/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $25.00 -> $27.00 | Low | View details for Oppenheimer rating of Nurix Therapeutics (NASDAQ:NRIX) on 8/14/2024 |
CATX Perspective Therapeutics | $15.10
-4.7% | 8/13/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $19.00 -> $17.00 | Low | View details for Oppenheimer rating of Perspective Therapeutics (NYSE:CATX) on 8/13/2024 |
ATXS Astria Therapeutics | $11.14
+4.9% | 8/13/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $25.00 -> $26.00 | Low | View details for Oppenheimer rating of Astria Therapeutics (NASDAQ:ATXS) on 8/13/2024 |
MAIN Main Street Capital | $49.95
+0.9% | 8/13/2024 | Target Raised by | Oppenheimer | - | Market Perform -> Market Perform | $43.00 -> $44.00 | Low | View details for Oppenheimer rating of Main Street Capital (NYSE:MAIN) on 8/13/2024 |
ORIC ORIC Pharmaceuticals | $9.89
+9.2% | 8/13/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $17.00 -> $15.00 | Low | View details for Oppenheimer rating of ORIC Pharmaceuticals (NASDAQ:ORIC) on 8/13/2024 |
PACS PACS Group | $40.72
+1.8% | 8/13/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $32.00 -> $40.00 | Low | View details for Oppenheimer rating of PACS Group (NYSE:PACS) on 8/13/2024 |
APLE Apple Hospitality REIT | $14.28
+0.8% | 8/12/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $19.00 -> $17.00 | Low | View details for Oppenheimer rating of Apple Hospitality REIT (NYSE:APLE) on 8/12/2024 |
HST Host Hotels & Resorts | $17.42
+1.3% | 8/12/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $24.00 -> $22.00 | Low | View details for Oppenheimer rating of Host Hotels & Resorts (NASDAQ:HST) on 8/12/2024 |
INO Inovio Pharmaceuticals | $6.81
+2.7% | 8/12/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $40.00 -> $33.00 | Low | View details for Oppenheimer rating of Inovio Pharmaceuticals (NASDAQ:INO) on 8/12/2024 |
TARA Protara Therapeutics | $1.88
+8.7% | 8/12/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $30.00 -> $25.00 | Low | View details for Oppenheimer rating of Protara Therapeutics (NASDAQ:TARA) on 8/12/2024 |
VRDN Viridian Therapeutics | $22.06
+6.6% | 8/12/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $31.00 -> $28.00 | Low | View details for Oppenheimer rating of Viridian Therapeutics (NASDAQ:VRDN) on 8/12/2024 |
SLNO Soleno Therapeutics | $52.84
+6.5% | 8/12/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $59.00 -> $65.00 | Low | View details for Oppenheimer rating of Soleno Therapeutics (NASDAQ:SLNO) on 8/12/2024 |
CCSI Consensus Cloud Solutions | $22.53
+3.5% | 8/9/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $20.00 -> $23.00 | Low | View details for Oppenheimer rating of Consensus Cloud Solutions (NASDAQ:CCSI) on 8/9/2024 |
CRNX Crinetics Pharmaceuticals | $53.80
+5.0% | 8/9/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $74.00 -> $73.00 | Low | View details for Oppenheimer rating of Crinetics Pharmaceuticals (NASDAQ:CRNX) on 8/9/2024 |
GCMG GCM Grosvenor | $11.06
+1.8% | 8/9/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $15.00 -> $14.00 | Low | View details for Oppenheimer rating of GCM Grosvenor (NASDAQ:GCMG) on 8/9/2024 |
IMCR Immunocore | $33.55
+1.6% | 8/9/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $87.00 -> $89.00 | Low | View details for Oppenheimer rating of Immunocore (NASDAQ:IMCR) on 8/9/2024 |
SG Sweetgreen | $34.58
+1.9% | 8/9/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $34.00 -> $36.00 | Low | View details for Oppenheimer rating of Sweetgreen (NYSE:SG) on 8/9/2024 |
War on Elon Escalates… (Ad) Elon Musk just built a supercomputer in Memphis, Tennessee.
It took him only 122 days.
Dubbed “Colossus,” this supercomputer aims to become the most powerful AI training system in the world.
Housed in a 785,000 sq. ft facility in Memphis, Colossus will soon require 150 megawatts of electricity per day.
That’s about equal to the amount of energy needed to power 100,000 homes per year. Click here and take notes. |
TARS Tarsus Pharmaceuticals | $33.26
+4.9% | 8/9/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $61.00 -> $63.00 | Low | View details for Oppenheimer rating of Tarsus Pharmaceuticals (NASDAQ:TARS) on 8/9/2024 |
VVI Viad | $33.25
+2.1% | 8/9/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $43.00 -> $41.00 | Low | View details for Oppenheimer rating of Viad (NYSE:VVI) on 8/9/2024 |
PET Wag! Group | $0.74
-0.3% | 8/9/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $6.00 -> $3.00 | Low | View details for Oppenheimer rating of Wag! Group (NASDAQ:PET) on 8/9/2024 |
AMPX Amprius Technologies | $0.89
+3.5% | 8/9/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $15.00 -> $14.00 | Low | View details for Oppenheimer rating of Amprius Technologies (NYSE:AMPX) on 8/9/2024 |
ARRY Array Technologies | $6.82
+2.1% | 8/9/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $20.00 -> $17.00 | N/A | View details for Oppenheimer rating of Array Technologies (NASDAQ:ARRY) on 8/9/2024 |
AORT Artivion | $25.25
+2.0% | 8/9/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $25.00 -> $30.00 | Low | View details for Oppenheimer rating of Artivion (NYSE:AORT) on 8/9/2024 |
BLZE Backblaze | $6.18
+4.4% | 8/9/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $11.00 -> $10.00 | Low | View details for Oppenheimer rating of Backblaze (NASDAQ:BLZE) on 8/9/2024 |
CARG CarGurus | $29.12
+2.5% | 8/9/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $30.00 -> $32.00 | Low | View details for Oppenheimer rating of CarGurus (NASDAQ:CARG) on 8/9/2024 |
HEAR Turtle Beach | $14.26
+3.1% | 8/9/2024 | Upgraded by | Oppenheimer | - | Market Perform -> Outperform | $17.00 | N/A | View details for Oppenheimer rating of Turtle Beach (NASDAQ:HEAR) on 8/9/2024 |
APP AppLovin | $112.58
+6.6% | 8/8/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $97.00 -> $105.00 | Low | View details for Oppenheimer rating of AppLovin (NASDAQ:APP) on 8/8/2024 |
BLDR Builders FirstSource | $183.30
+4.3% | 8/8/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $230.00 -> $190.00 | Low | View details for Oppenheimer rating of Builders FirstSource (NYSE:BLDR) on 8/8/2024 |
PLYA Playa Hotels & Resorts | $7.77
+1.7% | 8/8/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $12.00 -> $10.00 | Low | View details for Oppenheimer rating of Playa Hotels & Resorts (NASDAQ:PLYA) on 8/8/2024 |
RXO RXO | $25.70
+0.6% | 8/8/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $22.00 -> $31.00 | Low | View details for Oppenheimer rating of RXO (NYSE:RXO) on 8/8/2024 |
PRCH Porch Group | $1.34
+5.5% | 8/8/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $4.50 -> $3.50 | Low | View details for Oppenheimer rating of Porch Group (NASDAQ:PRCH) on 8/8/2024 |
CEVA CEVA | $24.92
+3.2% | 8/8/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $29.00 -> $33.00 | Low | View details for Oppenheimer rating of CEVA (NASDAQ:CEVA) on 8/8/2024 |
COST Costco Wholesale | $916.00
+0.1% | 8/8/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $950.00 -> $925.00 | Low | View details for Oppenheimer rating of Costco Wholesale (NASDAQ:COST) on 8/8/2024 |
EMR Emerson Electric | $102.03
+0.6% | 8/8/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $125.00 -> $120.00 | Low | View details for Oppenheimer rating of Emerson Electric (NYSE:EMR) on 8/8/2024 |
ORA Ormat Technologies | $75.93
+2.3% | 8/8/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $85.00 -> $86.00 | Low | View details for Oppenheimer rating of Ormat Technologies (NYSE:ORA) on 8/8/2024 |
ROK Rockwell Automation | $262.92
+1.9% | 8/8/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $295.00 -> $270.00 | Low | View details for Oppenheimer rating of Rockwell Automation (NYSE:ROK) on 8/8/2024 |
ALLO Allogene Therapeutics | $2.96
+11.3% | 8/8/2024 | Initiated by | Oppenheimer | - | Outperform | $13.00 -> $11.00 | Low | View details for Oppenheimer rating of Allogene Therapeutics (NASDAQ:ALLO) on 8/8/2024 |
TYRA Tyra Biosciences | $21.24
+3.4% | 8/8/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $28.00 -> $25.00 | Low | View details for Oppenheimer rating of Tyra Biosciences (NASDAQ:TYRA) on 8/8/2024 |
PLRX Pliant Therapeutics | $12.00
+1.4% | 8/8/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $48.00 -> $45.00 | N/A | View details for Oppenheimer rating of Pliant Therapeutics (NASDAQ:PLRX) on 8/8/2024 |
ZBH Zimmer Biomet | $106.26
+1.1% | 8/8/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $155.00 -> $145.00 | N/A | View details for Oppenheimer rating of Zimmer Biomet (NYSE:ZBH) on 8/8/2024 |
PNTG The Pennant Group | $34.52
+3.7% | 8/8/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $28.00 -> $34.00 | N/A | View details for Oppenheimer rating of The Pennant Group (NASDAQ:PNTG) on 8/8/2024 |
FROG JFrog | $27.99
+0.3% | 8/8/2024 | Downgraded by | Oppenheimer | - | Outperform -> Market Perform | | Low | View details for Oppenheimer rating of JFrog (NASDAQ:FROG) on 8/8/2024 |
AMGN Amgen | $332.45
+0.7% | 8/7/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $380.00 -> $380.00 | Low | View details for Oppenheimer rating of Amgen (NASDAQ:AMGN) on 8/7/2024 |
GBDC Golub Capital BDC | $15.09
+1.5% | 8/7/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $17.00 -> $17.00 | Low | View details for Oppenheimer rating of Golub Capital BDC (NASDAQ:GBDC) on 8/7/2024 |
TRMB Trimble | $56.50
+1.5% | 8/7/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $72.00 -> $72.00 | Low | View details for Oppenheimer rating of Trimble (NASDAQ:TRMB) on 8/7/2024 |
OLMA Olema Pharmaceuticals | $12.70
+7.2% | 8/7/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $30.00 -> $30.00 | Low | View details for Oppenheimer rating of Olema Pharmaceuticals (NASDAQ:OLMA) on 8/7/2024 |
BCYC Bicycle Therapeutics | $27.02
-0.8% | 8/7/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $48.00 -> $48.00 | Low | View details for Oppenheimer rating of Bicycle Therapeutics (NASDAQ:BCYC) on 8/7/2024 |
IDYA IDEAYA Biosciences | $37.46
+3.7% | 8/7/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $60.00 -> $53.00 | Low | View details for Oppenheimer rating of IDEAYA Biosciences (NASDAQ:IDYA) on 8/7/2024 |
RLAY Relay Therapeutics | $7.60
-0.3% | 8/7/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $25.00 -> $24.00 | Low | View details for Oppenheimer rating of Relay Therapeutics (NASDAQ:RLAY) on 8/7/2024 |
RUN Sunrun | $19.23
+2.4% | 8/7/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $19.00 -> $22.00 | Low | View details for Oppenheimer rating of Sunrun (NASDAQ:RUN) on 8/7/2024 |
ADUS Addus HomeCare | $130.13
+1.3% | 8/7/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $130.00 -> $140.00 | Low | View details for Oppenheimer rating of Addus HomeCare (NASDAQ:ADUS) on 8/7/2024 |
CRBP Corbus Pharmaceuticals | $55.81
+8.2% | 8/7/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $80.00 -> $88.00 | Low | View details for Oppenheimer rating of Corbus Pharmaceuticals (NASDAQ:CRBP) on 8/7/2024 |
NYXH Nyxoah | $7.84
| 8/7/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $15.00 -> $13.00 | Low | View details for Oppenheimer rating of Nyxoah (NASDAQ:NYXH) on 8/7/2024 |
JACK Jack in the Box | $44.41
+3.6% | 8/7/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $75.00 -> $70.00 | Low | View details for Oppenheimer rating of Jack in the Box (NASDAQ:JACK) on 8/7/2024 |
INGR Ingredion | $134.60
-0.2% | 8/7/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $126.00 -> $138.00 | N/A | View details for Oppenheimer rating of Ingredion (NYSE:INGR) on 8/7/2024 |
SHLS Shoals Technologies Group | $6.35
-2.0% | 8/7/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $14.00 -> $12.00 | N/A | View details for Oppenheimer rating of Shoals Technologies Group (NASDAQ:SHLS) on 8/7/2024 |
MWA Mueller Water Products | $20.22
+1.9% | 8/7/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $22.00 -> $24.00 | N/A | View details for Oppenheimer rating of Mueller Water Products (NYSE:MWA) on 8/7/2024 |
CTOS Custom Truck One Source | $3.73
+4.8% | 8/7/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $7.00 -> $6.00 | N/A | View details for Oppenheimer rating of Custom Truck One Source (NYSE:CTOS) on 8/7/2024 |
GPRE Green Plains | $12.58
+2.6% | 8/7/2024 | Downgraded by | Oppenheimer | - | Outperform -> Market Perform | | Low | View details for Oppenheimer rating of Green Plains (NASDAQ:GPRE) on 8/7/2024 |
RXST RxSight | $54.96
+0.8% | 8/6/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $72.00 -> $65.00 | Low | View details for Oppenheimer rating of RxSight (NASDAQ:RXST) on 8/6/2024 |
CG The Carlyle Group | $40.05
+3.3% | 8/6/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $69.00 -> $64.00 | Low | View details for Oppenheimer rating of The Carlyle Group (NASDAQ:CG) on 8/6/2024 |
VRTX Vertex Pharmaceuticals | $485.37
+1.4% | 8/5/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $500.00 -> $550.00 | Low | View details for Oppenheimer rating of Vertex Pharmaceuticals (NASDAQ:VRTX) on 8/5/2024 |
DKNG DraftKings | $37.80
-2.0% | 8/5/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $58.00 -> $55.00 | Low | View details for Oppenheimer rating of DraftKings (NASDAQ:DKNG) on 8/5/2024 |
IEX IDEX | $199.78
+0.8% | 8/5/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $245.00 -> $238.00 | Low | View details for Oppenheimer rating of IDEX (NYSE:IEX) on 8/5/2024 |
LSEA Landsea Homes | $12.48
+6.1% | 8/5/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $14.00 -> $15.00 | Low | View details for Oppenheimer rating of Landsea Homes (NASDAQ:LSEA) on 8/5/2024 |
PRAX Praxis Precision Medicines | $59.88
+2.0% | 8/5/2024 | Initiated by | Oppenheimer | - | Outperform | $134.00 | Low | View details for Oppenheimer rating of Praxis Precision Medicines (NASDAQ:PRAX) on 8/5/2024 |
WSC WillScot Mobile Mini | $39.16
-0.2% | 8/2/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $53.00 -> $46.00 | Low | View details for Oppenheimer rating of WillScot Mobile Mini (NASDAQ:WSC) on 8/2/2024 |
Kamala’s Dirty Election Move… Revealed (Ad) According to former advisor to the CIA, the Pentagon and the White House Jim Rickards…
Kamala and her puppet masters are planning this dirty election move…
 Click here now and learn how to prepare. |
LUMO Lumos Pharma | $3.93
+5.4% | 8/2/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $16.00 -> $13.00 | Low | View details for Oppenheimer rating of Lumos Pharma (NASDAQ:LUMO) on 8/2/2024 |
IRTC iRhythm Technologies | $76.61
+2.5% | 8/2/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $165.00 -> $145.00 | Low | View details for Oppenheimer rating of iRhythm Technologies (NASDAQ:IRTC) on 8/2/2024 |
NBIX Neurocrine Biosciences | $122.25
+0.8% | 8/2/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $216.00 -> $219.00 | Low | View details for Oppenheimer rating of Neurocrine Biosciences (NASDAQ:NBIX) on 8/2/2024 |
DASH DoorDash | $131.35
+0.9% | 8/2/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $125.00 -> $145.00 | Low | View details for Oppenheimer rating of DoorDash (NASDAQ:DASH) on 8/2/2024 |
BKNG Booking | $3,932.59
+1.6% | 8/2/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $4,600.00 -> $4,200.00 | Low | View details for Oppenheimer rating of Booking (NASDAQ:BKNG) on 8/2/2024 |
TEAM Atlassian | $163.74
-1.2% | 8/2/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $250.00 -> $230.00 | Low | View details for Oppenheimer rating of Atlassian (NASDAQ:TEAM) on 8/2/2024 |
RGLS Regulus Therapeutics | $1.61
+1.9% | 8/2/2024 | Initiated by | Oppenheimer | - | Outperform | $7.00 | Low | View details for Oppenheimer rating of Regulus Therapeutics (NASDAQ:RGLS) on 8/2/2024 |
RANI Rani Therapeutics | $2.37
-0.8% | 8/2/2024 | Initiated by | Oppenheimer | - | Outperform | $17.00 | Low | View details for Oppenheimer rating of Rani Therapeutics (NASDAQ:RANI) on 8/2/2024 |
OCSL Oaktree Specialty Lending | $16.54
+0.8% | 8/2/2024 | Downgraded by | Oppenheimer | - | Outperform -> Market Perform | $20.00 -> $18.00 | Low | View details for Oppenheimer rating of Oaktree Specialty Lending (NASDAQ:OCSL) on 8/2/2024 |
OWL Blue Owl Capital | $17.54
+2.1% | 8/2/2024 | Upgraded by | Oppenheimer | - | Market Perform -> Outperform | $21.00 | Low | View details for Oppenheimer rating of Blue Owl Capital (NYSE:OWL) on 8/2/2024 |
CLH Clean Harbors | $243.97
+1.5% | 8/1/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $245.00 -> $252.00 | Low | View details for Oppenheimer rating of Clean Harbors (NYSE:CLH) on 8/1/2024 |
NGVT Ingevity | $38.56
+8.3% | 8/1/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $58.00 -> $50.00 | Low | View details for Oppenheimer rating of Ingevity (NYSE:NGVT) on 8/1/2024 |
KKR KKR & Co. Inc. | $122.80
+2.0% | 8/1/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $121.00 -> $128.00 | Low | View details for Oppenheimer rating of KKR & Co. Inc. (NYSE:KKR) on 8/1/2024 |
MOD Modine Manufacturing | $111.07
+0.2% | 8/1/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $114.00 -> $135.00 | Low | View details for Oppenheimer rating of Modine Manufacturing (NYSE:MOD) on 8/1/2024 |
NRDS NerdWallet | $12.88
+2.8% | 8/1/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $20.00 -> $18.00 | Low | View details for Oppenheimer rating of NerdWallet (NASDAQ:NRDS) on 8/1/2024 |
TMDX TransMedics Group | $151.42
+1.5% | 8/1/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $125.00 -> $200.00 | Low | View details for Oppenheimer rating of TransMedics Group (NASDAQ:TMDX) on 8/1/2024 |
HUM Humana | $321.56
-0.9% | 8/1/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $370.00 -> $400.00 | Low | View details for Oppenheimer rating of Humana (NYSE:HUM) on 8/1/2024 |
TDOC Teladoc Health | $8.09
+6.2% | 8/1/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $21.00 -> $17.00 | Low | View details for Oppenheimer rating of Teladoc Health (NYSE:TDOC) on 8/1/2024 |
RSI Rush Street Interactive | $10.07
+0.7% | 8/1/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $10.00 -> $14.00 | Low | View details for Oppenheimer rating of Rush Street Interactive (NYSE:RSI) on 8/1/2024 |
META Meta Platforms | $524.62
-0.2% | 8/1/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $525.00 -> $615.00 | Low | View details for Oppenheimer rating of Meta Platforms (NASDAQ:META) on 8/1/2024 |
ZETA Zeta Global | $27.52
+2.0% | 8/1/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $20.00 -> $29.00 | Low | View details for Oppenheimer rating of Zeta Global (NASDAQ:ZETA) on 8/1/2024 |
ETSY Etsy | $55.65
+7.6% | 8/1/2024 | Downgraded by | Oppenheimer | - | Outperform -> Market Perform | | Low | View details for Oppenheimer rating of Etsy (NASDAQ:ETSY) on 8/1/2024 |
ARVN Arvinas | $25.05
+2.2% | 7/31/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $70.00 -> $50.00 | Low | View details for Oppenheimer rating of Arvinas (NASDAQ:ARVN) on 7/31/2024 |
GLW Corning | $42.50
+1.5% | 7/31/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $50.00 -> $47.00 | Low | View details for Oppenheimer rating of Corning (NYSE:GLW) on 7/31/2024 |
DENN Denny's | $6.37
+8.7% | 7/31/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $11.00 -> $10.00 | Low | View details for Oppenheimer rating of Denny’s (NASDAQ:DENN) on 7/31/2024 |
FSLR First Solar | $228.79
-3.0% | 7/31/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $325.00 -> $326.00 | Low | View details for Oppenheimer rating of First Solar (NASDAQ:FSLR) on 7/31/2024 |
PRO PROS | $17.84
+3.7% | 7/31/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $42.00 -> $31.00 | Low | View details for Oppenheimer rating of PROS (NYSE:PRO) on 7/31/2024 |
SPGI S&P Global | $519.45
-0.1% | 7/31/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $486.00 -> $540.00 | Low | View details for Oppenheimer rating of S&P Global (NYSE:SPGI) on 7/31/2024 |
ST Sensata Technologies | $34.66
+1.5% | 7/31/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $50.00 -> $47.00 | Low | View details for Oppenheimer rating of Sensata Technologies (NYSE:ST) on 7/31/2024 |
EXEL Exelixis | $26.46
+0.6% | 7/30/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $29.00 -> $29.00 | Low | View details for Oppenheimer rating of Exelixis (NASDAQ:EXEL) on 7/30/2024 |
NFLX Netflix | $697.06
+1.5% | 7/30/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $725.00 -> $725.00 | Low | View details for Oppenheimer rating of Netflix (NASDAQ:NFLX) on 7/30/2024 |
TREE LendingTree | $57.27
+5.2% | 7/30/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $55.00 -> $65.00 | Low | View details for Oppenheimer rating of LendingTree (NASDAQ:TREE) on 7/30/2024 |
BLDR Builders FirstSource | $183.30
+4.3% | 7/29/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $242.00 -> $230.00 | Low | View details for Oppenheimer rating of Builders FirstSource (NYSE:BLDR) on 7/29/2024 |
CNC Centene | $75.35
+0.7% | 7/29/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $110.00 -> $95.00 | Low | View details for Oppenheimer rating of Centene (NYSE:CNC) on 7/29/2024 |
WT WisdomTree | $9.55
+1.6% | 7/29/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $12.00 -> $13.00 | Low | View details for Oppenheimer rating of WisdomTree (NYSE:WT) on 7/29/2024 |
NDAQ Nasdaq | $73.00
+0.6% | 7/26/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $72.00 -> $75.00 | Low | View details for Oppenheimer rating of Nasdaq (NASDAQ:NDAQ) on 7/26/2024 |
DXCM DexCom | $69.51
+1.0% | 7/26/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $150.00 -> $115.00 | Low | View details for Oppenheimer rating of DexCom (NASDAQ:DXCM) on 7/26/2024 |
INCY Incyte | $63.56
+0.3% | 7/26/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $84.00 -> $81.00 | Low | View details for Oppenheimer rating of Incyte (NASDAQ:INCY) on 7/26/2024 |
CARR Carrier Global | $76.51
+1.5% | 7/26/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $71.00 -> $70.00 | Low | View details for Oppenheimer rating of Carrier Global (NYSE:CARR) on 7/26/2024 |
WM Waste Management | $208.05
+0.1% | 7/26/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $229.00 -> $224.00 | Low | View details for Oppenheimer rating of Waste Management (NYSE:WM) on 7/26/2024 |
POOL Pool | $356.02
+2.8% | 7/26/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $356.00 -> $380.00 | Low | View details for Oppenheimer rating of Pool (NASDAQ:POOL) on 7/26/2024 |
TPH Tri Pointe Homes | $44.56
+3.7% | 7/26/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $46.00 -> $54.00 | Low | View details for Oppenheimer rating of Tri Pointe Homes (NYSE:TPH) on 7/26/2024 |
TRU TransUnion | $100.39
+2.3% | 7/26/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $90.00 -> $97.00 | Low | View details for Oppenheimer rating of TransUnion (NYSE:TRU) on 7/26/2024 |
TYL Tyler Technologies | $581.96
-0.2% | 7/26/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $550.00 -> $625.00 | Low | View details for Oppenheimer rating of Tyler Technologies (NYSE:TYL) on 7/26/2024 |
T AT&T | $21.64
+0.2% | 7/25/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $21.00 -> $23.00 | Low | View details for Oppenheimer rating of AT&T (NYSE:T) on 7/25/2024 |
CMG Chipotle Mexican Grill | $56.12
-0.4% | 7/25/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $70.00 -> $65.00 | Low | View details for Oppenheimer rating of Chipotle Mexican Grill (NYSE:CMG) on 7/25/2024 |
CYH Community Health Systems | $5.72
+2.1% | 7/25/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $4.50 -> $5.00 | Low | View details for Oppenheimer rating of Community Health Systems (NYSE:CYH) on 7/25/2024 |
EW Edwards Lifesciences | $68.52
+0.6% | 7/25/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $100.00 -> $90.00 | Low | View details for Oppenheimer rating of Edwards Lifesciences (NYSE:EW) on 7/25/2024 |
RSG Republic Services | $205.79
+0.3% | 7/25/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $211.00 -> $210.00 | Low | View details for Oppenheimer rating of Republic Services (NYSE:RSG) on 7/25/2024 |
ROP Roper Technologies | $551.84
+0.1% | 7/25/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $650.00 -> $630.00 | Low | View details for Oppenheimer rating of Roper Technologies (NYSE:ROP) on 7/25/2024 |
Kamala’s Dirty Election Move… Revealed (Ad) According to former advisor to the CIA, the Pentagon and the White House Jim Rickards…
Kamala and her puppet masters are planning this dirty election move…
Click here now and learn how to prepare. |
MCO Moody's | $476.96
-0.4% | 7/24/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $454.00 -> $492.00 | Low | View details for Oppenheimer rating of Moody’s (NYSE:MCO) on 7/24/2024 |
PHM PulteGroup | $139.54
+3.1% | 7/24/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $143.00 -> $151.00 | Low | View details for Oppenheimer rating of PulteGroup (NYSE:PHM) on 7/24/2024 |
UPS United Parcel Service | $127.24
-0.9% | 7/24/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $157.00 -> $140.00 | Low | View details for Oppenheimer rating of United Parcel Service (NYSE:UPS) on 7/24/2024 |
HCA HCA Healthcare | $394.68
+0.8% | 7/24/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $345.00 -> $390.00 | Low | View details for Oppenheimer rating of HCA Healthcare (NYSE:HCA) on 7/24/2024 |
PNR Pentair | $91.49
+0.8% | 7/24/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $92.00 -> $98.00 | Low | View details for Oppenheimer rating of Pentair (NYSE:PNR) on 7/24/2024 |
GOOG Alphabet | $158.37
+1.8% | 7/24/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $205.00 -> $210.00 | Low | View details for Oppenheimer rating of Alphabet (NASDAQ:GOOG) on 7/24/2024 |
ARGX argenx | $538.01
+0.4% | 7/23/2024 | Upgraded by | Oppenheimer | - | Market Perform -> Outperform | $546.00 -> $546.00 | Low | View details for Oppenheimer rating of argenx (NASDAQ:ARGX) on 7/23/2024 |
AGCO AGCO | $90.93
+1.8% | 7/22/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $133.00 -> $132.00 | Low | View details for Oppenheimer rating of AGCO (NYSE:AGCO) on 7/22/2024 |
BILL BILL | $51.91
+0.1% | 7/22/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $95.00 -> $70.00 | Low | View details for Oppenheimer rating of BILL (NYSE:BILL) on 7/22/2024 |
HUBS HubSpot | $491.17
-0.3% | 7/22/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $725.00 -> $625.00 | Low | View details for Oppenheimer rating of HubSpot (NYSE:HUBS) on 7/22/2024 |
BKNG Booking | $3,932.59
+1.6% | 7/22/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $4,200.00 -> $4,600.00 | Low | View details for Oppenheimer rating of Booking (NASDAQ:BKNG) on 7/22/2024 |
DE Deere & Company | $394.68
+2.0% | 7/22/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $465.00 -> $448.00 | Low | View details for Oppenheimer rating of Deere & Company (NYSE:DE) on 7/22/2024 |
GPRE Green Plains | $12.58
+2.6% | 7/22/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $28.00 -> $21.00 | Low | View details for Oppenheimer rating of Green Plains (NASDAQ:GPRE) on 7/22/2024 |
AVBP ArriVent BioPharma | $23.76
-0.1% | 7/22/2024 | Initiated by | Oppenheimer | - | Outperform | $35.00 | Low | View details for Oppenheimer rating of ArriVent BioPharma (NASDAQ:AVBP) on 7/22/2024 |
AGYS Agilysys | $102.17
+1.1% | 7/19/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $100.00 -> $120.00 | Low | View details for Oppenheimer rating of Agilysys (NASDAQ:AGYS) on 7/19/2024 |
EFX Equifax | $306.75
+3.0% | 7/19/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $272.00 -> $300.00 | Low | View details for Oppenheimer rating of Equifax (NYSE:EFX) on 7/19/2024 |
META Meta Platforms | $524.62
-0.2% | 7/19/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $500.00 -> $525.00 | Low | View details for Oppenheimer rating of Meta Platforms (NASDAQ:META) on 7/19/2024 |
CNTA Centessa Pharmaceuticals | $16.99
+12.5% | 7/18/2024 | Initiated by | Oppenheimer | - | Outperform | $14.00 | Low | View details for Oppenheimer rating of Centessa Pharmaceuticals (NASDAQ:CNTA) on 7/18/2024 |
SPXC SPX Technologies | $151.00
+1.5% | 7/18/2024 | Downgraded by | Oppenheimer | - | Outperform -> Market Perform | | Low | View details for Oppenheimer rating of SPX Technologies (NYSE:SPXC) on 7/18/2024 |
ITRI Itron | $102.54
+3.0% | 7/17/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $110.00 -> $112.00 | Low | View details for Oppenheimer rating of Itron (NASDAQ:ITRI) on 7/17/2024 |
MS Morgan Stanley | $98.25
+1.7% | 7/17/2024 | Downgraded by | Oppenheimer | - | Outperform -> Market Perform | | Low | View details for Oppenheimer rating of Morgan Stanley (NYSE:MS) on 7/17/2024 |
AVGO Broadcom | $167.69
+1.9% | 7/16/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $2,000.00 -> $200.00 | Low | View details for Oppenheimer rating of Broadcom (NASDAQ:AVGO) on 7/16/2024 |
EA Electronic Arts | $145.83
+0.7% | 7/16/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $150.00 -> $170.00 | Low | View details for Oppenheimer rating of Electronic Arts (NASDAQ:EA) on 7/16/2024 |
RVMD Revolution Medicines | $43.70
+4.1% | 7/16/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $45.00 -> $55.00 | Low | View details for Oppenheimer rating of Revolution Medicines (NASDAQ:RVMD) on 7/16/2024 |
GS The Goldman Sachs Group | $478.99
+1.0% | 7/16/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $504.00 -> $559.00 | Low | View details for Oppenheimer rating of The Goldman Sachs Group (NYSE:GS) on 7/16/2024 |
PNR Pentair | $91.49
+0.8% | 7/16/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $90.00 -> $92.00 | Low | View details for Oppenheimer rating of Pentair (NYSE:PNR) on 7/16/2024 |
ITGR Integer | $126.78
+0.5% | 7/16/2024 | Initiated by | Oppenheimer | - | Outperform | $135.00 | Low | View details for Oppenheimer rating of Integer (NYSE:ITGR) on 7/16/2024 |
C Citigroup | $57.67
+0.6% | 7/15/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $85.00 -> $86.00 | Low | View details for Oppenheimer rating of Citigroup (NYSE:C) on 7/15/2024 |
JPM JPMorgan Chase & Co. | $204.32
-1.1% | 7/15/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $215.00 -> $221.00 | Low | View details for Oppenheimer rating of JPMorgan Chase & Co. (NYSE:JPM) on 7/15/2024 |
RSG Republic Services | $205.79
+0.3% | 7/15/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $204.00 -> $211.00 | Low | View details for Oppenheimer rating of Republic Services (NYSE:RSG) on 7/15/2024 |
WCN Waste Connections | $185.68
-0.2% | 7/15/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $181.00 -> $191.00 | Low | View details for Oppenheimer rating of Waste Connections (NYSE:WCN) on 7/15/2024 |
WM Waste Management | $208.05
+0.1% | 7/15/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $228.00 -> $229.00 | Low | View details for Oppenheimer rating of Waste Management (NYSE:WM) on 7/15/2024 |
ULTA Ulta Beauty | $378.34
+1.4% | 7/15/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $475.00 -> $450.00 | Low | View details for Oppenheimer rating of Ulta Beauty (NASDAQ:ULTA) on 7/15/2024 |
TTD Trade Desk | $106.06
+1.5% | 7/15/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $105.00 -> $120.00 | Low | View details for Oppenheimer rating of Trade Desk (NASDAQ:TTD) on 7/15/2024 |
NXPI NXP Semiconductors | $229.93
+2.1% | 7/12/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $295.00 -> $330.00 | Low | View details for Oppenheimer rating of NXP Semiconductors (NASDAQ:NXPI) on 7/12/2024 |
DPZ Domino's Pizza | $402.52
-0.8% | 7/12/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $580.00 -> $580.00 | Low | View details for Oppenheimer rating of Domino’s Pizza (NYSE:DPZ) on 7/12/2024 |
SKWD Skyward Specialty Insurance Group | $38.88
-1.1% | 7/12/2024 | Initiated by | Oppenheimer | - | Market Perform | | Low | View details for Oppenheimer rating of Skyward Specialty Insurance Group (NASDAQ:SKWD) on 7/12/2024 |
KNSL Kinsale Capital Group | $464.53
+1.6% | 7/12/2024 | Initiated by | Oppenheimer | - | Market Perform | | Low | View details for Oppenheimer rating of Kinsale Capital Group (NYSE:KNSL) on 7/12/2024 |
COST Costco Wholesale | $916.00
+0.1% | 7/11/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $905.00 -> $950.00 | Low | View details for Oppenheimer rating of Costco Wholesale (NASDAQ:COST) on 7/11/2024 |
ORIC ORIC Pharmaceuticals | $9.89
+9.2% | 7/10/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $17.00 -> $17.00 | Low | View details for Oppenheimer rating of ORIC Pharmaceuticals (NASDAQ:ORIC) on 7/10/2024 |
CRBP Corbus Pharmaceuticals | $55.81
+8.2% | 7/10/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $80.00 -> $80.00 | Low | View details for Oppenheimer rating of Corbus Pharmaceuticals (NASDAQ:CRBP) on 7/10/2024 |
KYMR Kymera Therapeutics | $46.08
+3.0% | 7/10/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $52.00 -> $52.00 | Low | View details for Oppenheimer rating of Kymera Therapeutics (NASDAQ:KYMR) on 7/10/2024 |
PLYA Playa Hotels & Resorts | $7.77
+1.7% | 7/10/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $12.00 -> $12.00 | Low | View details for Oppenheimer rating of Playa Hotels & Resorts (NASDAQ:PLYA) on 7/10/2024 |
CALC CalciMedica | $3.90
-6.3% | 7/10/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $14.00 -> $20.00 | Low | View details for Oppenheimer rating of CalciMedica (NASDAQ:CALC) on 7/10/2024 |
GLW Corning | $42.50
+1.5% | 7/10/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $40.00 -> $50.00 | Low | View details for Oppenheimer rating of Corning (NYSE:GLW) on 7/10/2024 |
ALB Albemarle | $87.44
-1.2% | 7/9/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $188.00 -> $178.00 | Low | View details for Oppenheimer rating of Albemarle (NYSE:ALB) on 7/9/2024 |
APTV Aptiv | $68.95
+2.9% | 7/9/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $145.00 -> $145.00 | Low | View details for Oppenheimer rating of Aptiv (NYSE:APTV) on 7/9/2024 |
TSLA Tesla | $230.29
+0.2% | 7/9/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Tesla (NASDAQ:TSLA) on 7/9/2024 |
WOLF Wolfspeed | $8.72
+8.3% | 7/9/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Wolfspeed (NYSE:WOLF) on 7/9/2024 |
ZETA Zeta Global | $27.52
+2.0% | 7/9/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $18.00 -> $20.00 | Low | View details for Oppenheimer rating of Zeta Global (NASDAQ:ZETA) on 7/9/2024 |
IDYA IDEAYA Biosciences | $37.46
+3.7% | 7/8/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $53.00 -> $60.00 | Low | View details for Oppenheimer rating of IDEAYA Biosciences (NASDAQ:IDYA) on 7/8/2024 |
BPMC Blueprint Medicines | $88.90
+5.7% | 7/8/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $114.00 -> $125.00 | Low | View details for Oppenheimer rating of Blueprint Medicines (NASDAQ:BPMC) on 7/8/2024 |
CWAN Clearwater Analytics | $24.01
+2.8% | 7/8/2024 | Upgraded by | Oppenheimer | - | Market Perform -> Outperform | $25.00 | Low | View details for Oppenheimer rating of Clearwater Analytics (NYSE:CWAN) on 7/8/2024 |
INTA Intapp | $44.84
+1.8% | 7/8/2024 | Reiterated by | Oppenheimer | - | Outperform -> Market Perform | | Low | View details for Oppenheimer rating of Intapp (NASDAQ:INTA) on 7/8/2024 |
HTZ Hertz Global | $3.00
+9.9% | 7/5/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | N/A | View details for Oppenheimer rating of Hertz Global (NASDAQ:HTZ) on 7/5/2024 |
TYRA Tyra Biosciences | $21.24
+3.4% | 7/3/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $28.00 -> $28.00 | Low | View details for Oppenheimer rating of Tyra Biosciences (NASDAQ:TYRA) on 7/3/2024 |
PHVS Pharvaris | $20.92
+1.9% | 7/3/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $36.00 -> $38.00 | Low | View details for Oppenheimer rating of Pharvaris (NASDAQ:PHVS) on 7/3/2024 |
OLED Universal Display | $209.15
+3.0% | 7/3/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $200.00 -> $250.00 | Low | View details for Oppenheimer rating of Universal Display (NASDAQ:OLED) on 7/3/2024 |
RNAC Cartesian Therapeutics | $16.75
+4.2% | 7/2/2024 | Downgraded by | Oppenheimer | - | Outperform -> Market Perform | | Low | View details for Oppenheimer rating of Cartesian Therapeutics (NASDAQ:RNAC) on 7/2/2024 |
TSLA Tesla | $230.29
+0.2% | 7/2/2024 | Reiterated by | Oppenheimer | - | Market Perform | | Low | View details for Oppenheimer rating of Tesla (NASDAQ:TSLA) on 7/2/2024 |
